rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Frank Bedu-Addo

President/CEO

Company insider

Files Form 4 as: President/CEO, PDS Biotechnology.

In numbers

Trades disclosed
15
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
0
First trade
28 Jun 2019
Last trade
12 Jan 2026
Last filed
3 Mar 2026

Companies traded

Where they are an officer
PDSB PDS BiotechnologyDirector, Officer, 10% owner · Biotechnology · last 12 Jan 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
12 Jan 2026filed 3 Mar 2026PDSB PDS Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—548,782 at $0.00filing
12 Jan 2026filed 3 Mar 2026PDSB PDS Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—548,782 at $0.00filing
12 Jun 2025filed 25 Jul 2025PDSB PDS Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—150,000 at $0.00filing
28 Feb 2024filed 25 Jul 2025PDSB PDS Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—300,000 at $0.00filing
5 Jan 2023filed 6 Jan 2023PDSB PDS Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—385,300 at $0.00filing
2 Dec 2022filed 2 Dec 2022PDSB PDS Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code M—219,535 at $0.00filing
2 Dec 2022filed 2 Dec 2022PDSB PDS BiotechnologyBiotechnologySEC FORM 4 Code M$1.4M219,535 at $6.57filing
2 Dec 2022filed 2 Dec 2022PDSB PDS BiotechnologyBiotechnologySEC FORM 4 Code F$1.7M175,184 at $9.78filing
19 Jan 2022filed 20 Jan 2022PDSB PDS Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—291,500 at $0.00filing
15 Jun 2021filed 17 Jun 2021PDSB PDS Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code M—53,174 at $0.00filing
15 Jun 2021filed 17 Jun 2021PDSB PDS BiotechnologyBiotechnologySEC FORM 4 Code M$349K53,174 at $6.57filing
15 Jun 2021filed 17 Jun 2021PDSB PDS BiotechnologyBiotechnologySEC FORM 4 Code F$349K27,166 at $12.86filing
8 Dec 2020filed 9 Dec 2020PDSB PDS Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—707,800 at $0.00filing
23 Jun 2020filed 25 Jun 2020PDSB PDS Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—125,000 at $0.00filing
28 Jun 2019filed 1 Jul 2019PDSB PDS Biotechnologyoption or derivative · BiotechnologySEC FORM 4 Code A—100,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

John Andrew DawsonDirector · Director at PDS Biotechnology, filing Form 4 there in the last year
Bruce WendelDirector · Director at PDS Biotechnology, filing Form 4 there in the last year
Deborah RamsdellDirector · Director at PDS Biotechnology, filing Form 4 there in the last year
Gregory Gene FreitagDirector · Director at PDS Biotechnology, filing Form 4 there in the last year
Kamil Ali-JacksonDirector · Director at PDS Biotechnology, filing Form 4 there in the last year